Furacilin: instructions for use, analogues and reviews, prices in Russian pharmacies. How to prepare a solution of furacilin from tablets Furacilin is used for treatment
Furacilin is an antibacterial and antiprotozoal agent for external and topical use..
pharmachologic effect
Active ingredient
Furacilina has an antimicrobial effect.
Unlike other chemotherapeutic agents, Furacilin has a different mechanism of action and forms highly reactive amino derivatives that cause conformational changes in macromolecular proteins, which leads to cell death.
Furacilin is active against most gram-positive and gram-negative bacteria, for example:
- Streptococcus spp.;
- Salmonella spp.;
- Staphylococcus spp.;
- Shigella (flexneri spp.., dysenteria spp., boydii spp., sonnei spp.);
- Clostridium perfringens;
- Escherichia coli..
Resistance to the active component of Furacilin develops slowly and, as a rule, does not reach a high degree. In addition, the tool helps to increase the activity of the reticuloendothelial system and enhance phagocytosis.
Release form Furacilin
The drug Furacilin is produced in the form:
- Alcoholic 0.067% solution for local and external use, in vials of 10 and 25 ml;
- Tablets for the preparation of a solution for topical use, 20 and 100 mg;
- Solution of 0.02% for local and external use, in vials of 200 and 400 ml;
- Pastes for external use, 1 and 2 kg each;
- Ointments 0.2% for local and external use, 25 g each.
Furacilin analogues are the following drugs:
- According to the active substance - Lifusol, Furaplast, Furatsilin-LekT;
- According to the mode of action - Kombutek-2.
Indications for use Furatsilina
According to the instructions, Furacilin is prescribed externally for the treatment of:
- pressure sores;
- Purulent wounds;
- Minor damage to the skin, including scratches, abrasions, cuts and cracks;
- Frostbite II-III degree;
- Burns II-III degree.
Locally Furacilin according to the instructions is used for:
- conjunctivitis;
- Gingivitis;
- Blepharitis;
- Empyema of the pleura and paranasal sinuses;
- osteomyelitis;
- Acute external and average otitis;
- urinary tract infections;
- stomatitis;
- Acute tonsillitis.
Contraindications
The use of Furacilin is contraindicated in the following cases:
- With bleeding;
- Against the background of existing allergic dermatoses;
- With hypersensitivity to the components of Furacilin.
How to use Furacilin
According to the indications, Furacilin can be used in various dosage forms.
In the treatment of blepharitis and conjunctivitis, Furacilin is used according to the instructions:
- Aqueous solution - in the form of instillation into the conjunctival sac;
- Ointment - to lubricate the edges of the eyelids.
For rinsing with furatsilin mouth
and throat, it is recommended to use a solution obtained from one tablet dissolved in 100 ml of water.
Furacilin in the form of an ointment is used to treat burns and frostbite of I-II degrees, as well as mucous membranes and superficial skin wounds. Duration of use - up to three days.
The use of Furacilin in the form of an alcohol solution (5-6 drops each) is effective in the treatment of otitis media. Before use, the solution should be warmed to body temperature. The remedy is recommended to be used daily until the symptoms of the disease disappear.
Outwardly, for irrigation of wounds and the application of wet dressings, both alcohol and aqueous solutions of Furacilin can be used.
Washing with Furacilin is effective for empyema of the paranasal sinuses, including sinusitis, for which an aqueous solution prepared or prepared from tablets is used.
In addition, flushing with Furacilin is effective:
- With osteomyelitis after surgery (followed by the imposition of a wet bandage);
- For washing the bladder and urethra (with exposure to an aqueous solution for 20 minutes);
- After removal of pus in pleural empyema (using an aqueous solution in an amount of 20-100 ml to wash the pleural cavity).
Side effects of furatsilina
When Furacilin is used according to indications, dermatitis and allergic reactions may develop in some cases.
Storage conditions
According to indications, Furacilin is dispensed from pharmacies without medical prescription. The shelf life of the drug is up to two years (subject to storage requirements).
Sincerely,
Chemical Name: 5-nitro-2-furaldehyde semicarbazone
General characteristics. The drug is a clear yellow solution
The composition of the medicinal product.
Release form: Solution for external use
Pharmacotherapeutic group: Antiseptics and disinfectants. Nitrofuran derivatives.
ATX code: D08AF01
pharmacological properties. Pharmacodynamics. An antimicrobial agent from the group of nitrofuran derivatives. It has a bacteriostatic effect on gram-positive and gram-negative bacteria (staphylococci, streptococci, E. coli, Proteus, Salmonella, Escherichia), as well as Trichomonas and Giardia.
Microorganisms resistant to antibiotics and sulfonamides are sensitive to furacilin. Resistance to furacilin develops slowly and does not reach a high degree.
Pharmacokinetics. With local and external use, absorption is negligible. When ingested, absorption is rapid and complete. Penetrates through histohematic barriers and is evenly distributed in fluids and tissues. The time required to reach maximum concentration is 6 hours. The main metabolic pathway is the reduction of the nitro group. It is excreted by the kidneys and partially through the intestines.
Indications for use
Purulent infected wounds, bedsores, ulcers;
Infected burns II and III degree;
Preparation of the granulating surface for skin grafts;
Osteomyelitis;
Pleural empyema;
Furuncle of the external auditory canal;
Empyema of the paranasal sinuses;
Conjunctivitis.
Dosage and administration
For purulent wounds, bedsores, ulcers, II and III degree burns, to prepare the granulating surface for skin grafting and for the secondary suture, irrigate the wound with an aqueous solution of furacilin and apply wet dressings.
In osteomyelitis, after surgery, the cavity is washed with an aqueous solution of furacilin and a wet bandage is applied.
With pleural empyema, pus is sucked off, the pleural cavity is washed, followed by the introduction of 20-100 ml of an aqueous solution of furacilin into the cavity.
In the treatment of boils of the external auditory canal and empyema of the paranasal sinuses, the damaged areas are washed 2-4-6 times a day (depending on the severity of the damage).
In the treatment of conjunctivitis - instillation of an aqueous solution into the conjunctival sac, 2-3 drops 3-4 times a day.
The duration of treatment is determined by the doctor, taking into account the characteristics of the disease, the tolerance of the drug and the effect achieved.
Side effect
When applied topically, furatsilin is usually well tolerated. In some cases, dermatitis is possible, requiring a temporary break or discontinuation of the drug. Bleeding.
In the event of adverse reactions, including those not listed in this leaflet, you should stop using the drug and consult a doctor.
Contraindications
Severe renal dysfunction;
Allergic dermatoses;
Hypersensitivity to nitrofuran derivatives.
Overdose
Precautionary measures
Due to the lack of sufficient data on the safety of use, the drug is not recommended for use in children and adolescents under the age of 18 years.
When using the drug, the so-called cross-sensitization is possible. To avoid sensitization, it is recommended to use the drug for no more than 5 days.
If during the use of the drug the symptoms of the disease persist or the condition worsens, it is necessary to stop using the drug and consult a doctor.
Use during pregnancy and lactation. When prescribing to pregnant women, women during lactation and children, it is recommended to take into account the possible balance of risk and benefit from the use of this drug.
Influence on the ability to drive vehicles and potentially dangerous mechanisms. There was no effect on the ability to drive vehicles and potentially dangerous mechanisms.
Interaction with other drugs
Incompatible with epinephrine (adrenaline), tetracaine, procaine (novocaine), resorcinol (resorcinol) and other reducing agents, as it decomposes to form pinkish or brownish colored products.
Incompatible with potassium permanganate, hydrogen peroxide and other oxidizing agents due to oxidation of the drug.
Latin name: Furacilin
ATX code: D08AF01
Active substance: Nitrofural
Manufacturer: Tatkhimfarmpreparaty, Russia
Pharmacy leave condition: Without recipe
Furacilin is one of the antiprotozoal drugs with antibacterial properties, can be applied topically and topically.
Indications for use Furatsilina
Not everyone knows exactly how Furacilin is used, what helps. An available antibacterial agent can be prescribed for both adults and children. Each of the forms of the drug Furacilin is very convenient to use. It is recommended to use drugs externally in such cases:
- Wound surfaces with suppuration
- bedsores
- Minor damage to the skin
- Frostbite and burns of varying severity.
Local use of the drug is indicated for:
- Acute tonsillitis
- stomatitis
- Blepharitis
- gingivitis
- Inflammatory process in the middle ear
- Osteomyelitis
- Infectious diseases of the urinary tract
- Conjunctivitis
- Empyema of the pleura and paranasal sinuses.
Composition of Furacilin
Furacilin tablets contain 20 mg of the main active ingredient, represented by nitrofural, as well as 0.8 mg of another substance, which is sodium chloride.
Furacilin effervescent (Avexima) includes 20 mg of the main active ingredient. Additionally present:
- Sodium carbonate and bicarbonate
- Wine acid
- macrogol
- Sodium chloride.
The basis of an aqueous solution of Furacilin is nitrofural and saline in a ratio of 1:5000.
The alcohol solution of Furacilin, in addition to nitrofural, contains 70% ethanol, the proportions of these components are 1:1500.
The ointment consists of 0.002 g of nitrofural, as well as white paraffin.
Medicinal properties of Furacilin
The active substance of this drug exhibits a pronounced antimicrobial effect.
Compared to other pharmaceutical drugs, it is characterized by a completely different principle of action. In contact with mucous membranes, the formation of highly reactive amino derivatives is observed, which lead to conformational changes within the proteins of pathogenic molecules. This results in the death of microbes.
Furacilin is active against gram-positive and gram-negative flora, including streptococci, salmonella, staphylococci, shigella.
The development of resistance to such a substance as nitrofural is slow, and generally does not reach maximum values. Along with this, the drug increases the activity of the reticuloendothelial system, and also enhances phagocytosis.
Release form
Price per tablet: from 60 to 110 rubles.
Tablets for the manufacture of a solution - Furacilin Avexima with a dosage of 20 mg are produced in packages. Each of them has 10 or 20 tab. (1 or 2 blisters) Furacelin Avexima, instructions.
Tablets intended for local use and oral administration with a dosage of 100 mg are available in packs of 12, 24 and 30 pcs.
The ointment, which is applied topically and externally, is packaged in jars, the volume of which is 25 g.
Furacilin solution 0.02% is produced in 100 ml glass bottles.
A solution of 0.067% is sold in bottles of 10 mg or 25 ml.
Furacilin tablets: instructions for use
The price of the ointment: from 35 to 82 rubles.
Not everyone knows how to use Furacilin, which helps. Along with this, information about whether it is possible to gargle with Furacilin is not at all known to everyone.
Of course, you can prepare a solution of Furacilin, as well as apply it to the throat (for rinsing) and treating damaged skin.
How to dilute Furacilin tablets
It is worth noting that Furacilin with angina is very effective, as it quickly eliminates the inflammatory process. Before you prepare a solution of Furacilin, you will need to grind one antibacterial tablet with a dosage of 20 mg. This powder must be poured with 100 ml of boiled water only. To increase the therapeutic effect of the ongoing treatment, add 2 teaspoons of a 3% hydrogen peroxide solution to the cooled solution. Rinsing with Furacilin for angina should be carried out at regular intervals of 4-6 p. throughout the day. The prepared solution of Furacilin for gargling can be used for a long time, it retains its antibacterial properties.
It must be remembered: Before diluting the antimicrobial tablet, you will first need to boil water, unboiled water is not used for this purpose.
Features of the use of Furacilin
Solution price: from 29 to 105 rubles.
In the treatment of acute bacterial dysentery, you should drink tablets four times a day, 1 tab. (best after meals) for 5-6 days. After a four-day break, you can start taking the medicine again.
A solution of Furacilin from tablets can be used to carry out the rinsing procedure for babies, it is recommended to carry it out under the strict supervision of an adult. Gargling with Furacilin for angina can be alternated with the procedure for irrigating the oral cavity with therapeutic aerosols (spray with anti-inflammatory action).
Furacilin for gargling can be used for a long time, you need to be treated until the observed symptoms disappear completely. Information on how to dilute Furacilin tablets, as well as how to make a solution from Furacilin Avexima correctly, should be provided by your doctor.
Furacilin solution for gargling can also be used for other purposes:
- With osteomyelitis in the postoperative period (it is necessary to apply a bandage)
- During the washing of the nasal sinuses, as well as the organs of the urinary system (an exposure lasting 20 minutes is carried out)
- After the procedure for removing purulent contents in case of pleural empyema.
Use of alcohol, aqueous solution
This dosage form is indicated for the treatment of various types of otitis media. The solution is instilled into the ear canal (5-6 drops) after preliminary warming up in the palms. Such procedures should be carried out every day until complete recovery.
It is also recommended for adults with children to wash the mucous membrane of the conjunctival sac with an aqueous antibacterial solution.
External use for irrigation of wound surfaces can be carried out with both an aqueous and alcoholic antibacterial solution of Furacilin.
Ointment Furacilin: instructions for use
The use of ointment is recommended for the treatment of burns, as well as frostbite of varying severity, as well as wound surfaces. Applications can be applied to both adults and children. Duration of application - up to 3 days.
Use during pregnancy and breastfeeding
The use of this antibacterial agent is allowed for this group of patients.
Contraindications
You should not use an antibacterial agent in the following cases:
- Tendency to bleed
- The presence of allergic dermatoses
- Excessive susceptibility to nitrofural.
Precautionary measures
It should be borne in mind that during the use of the drug, allergic reactions caused by sensitivity to the main component of the drug may develop.
Side effects
With prolonged use of the drug, inflammation of the skin, hyperemia can be observed. This is the main indication for the completion of ongoing therapy.
When taken orally, reactions from the gastrointestinal tract, allergies, dizziness can be diagnosed.
Overdose
There is an increase in the observed adverse symptoms.
Storage conditions and shelf life
It is recommended to store each of the dosage forms of Furacilin at a temperature not exceeding 25 C. The shelf life of antibacterial tablets for external use is 5 years, oral tablets - 4 years, antibacterial ointment with an alcohol-based solution - 2 years.
Analogues
Olainfarm, Latvia
Price from 116 to 367 rubles.
Furagin is a drug that has an antimicrobial effect. It should be used to eliminate the inflammatory process in the complex treatment of infectious diseases of the urinary system. The active substance of these tablets is furazidin.
Pros:
- Exhibits a wide spectrum of antimicrobial activity
- High efficiency
- Used in pediatrics.
Minuses:
- Contraindicated during pregnancy, lactation
- May cause angioedema
- Released by prescription.
in planimetric non-cell packing 10 pcs.; in a pack of cardboard 1 or 2 packs.
Description of the dosage form
Tablets are yellow or greenish-yellow in color with an uneven surface color.
pharmachologic effect
pharmachologic effect- antimicrobial.Pharmacodynamics
The antimicrobial agent, penetrating inside the microbial cell, lengthens the resting phase (interphase) and, thereby, inhibits division. Active against Gram-positive and Gram-negative bacteria (Staphylococcus spp., Streptococcus spp., Shigella dysenteriae spp., Shigella flexneri spp., Shigella boydii spp., Shigella sonnei spp., Escherichia coli, Clostridium perfringens, Salmonella spp. and etc.).
Indications of the drug Furacilin
purulent wounds;
bedsores;
burns II-III degree;
to prepare the granulating surface for skin grafts;
blepharitis;
conjunctivitis;
furuncles of the external auditory canal;
osteomyelitis;
empyema of the paranasal sinuses and pleura (washing of the cavities);
acute external and otitis media;
stomatitis;
gingivitis;
minor skin damage (including abrasions, scratches, cracks, cuts).
Contraindications
hypersensitivity;
chronic allergic dermatoses;
bleeding.
Side effects
Dermatitis is possible, requiring a temporary break or complete cessation of the use of the drug.
Dosage and administration
Outwardly, in the form of water 0.02% (1:5000) or alcohol 0.066% (1:1500) solutions - irrigate wounds and apply wet bandages. intracavitary- wash the maxillary and pleural cavity, oral cavity.
To prepare an aqueous solution, 1 part of nitrofural is dissolved in 5000 parts of isotonic sodium chloride solution or distilled water. The solution is sterilized at 100 °C for 30 minutes. An alcohol solution is prepared in 70% ethanol.
Storage conditions of the drug Furacilin
In a dry, dark place, at a temperature not exceeding 25 °C.Keep out of the reach of children.
Shelf life of the drug Furacilin
5 years.Do not use after the expiry date stated on the packaging.
Instructions for medical use
R N002885/01 dated 2018-04-19
Furacilin - instructions for medical use - RU No. LSR-009026/10 dated 2015-03-04
Furacilin - instructions for medical use - RU No. LSR-001149/10 dated 2018-11-06
Furacilin - instructions for medical use - RU No. LSR-009026/10 dated 2017-04-18
Furacilin - instructions for medical use - RU No. LP-003268 dated 2016-05-12
Furacilin - instructions for medical use - RU No. LP-004036 dated 2017-03-06
Furacilin - instructions for medical use - RU No. LP-003549 dated 2017-02-01
Furacilin - instructions for medical use - RU No. LP-002180 dated 2018-08-16
Synonyms of nosological groups
Category ICD-10 | Synonyms of diseases according to ICD-10 |
---|---|
H01.0 Blepharitis | Blepharitis |
Inflammation of the eyelids | |
Inflammatory diseases of the eyelids | |
Demodectic blepharitis | |
Superficial bacterial eye infection | |
Superficial infection of the eye | |
Scaly blepharitis | |
H10 Conjunctivitis | Bacterial conjunctivitis |
Conjunctivitis infectious and inflammatory | |
Superficial infection of the eye | |
red eye syndrome | |
Chronic non-infectious conjunctivitis | |
H10.9 Conjunctivitis, unspecified | Secondarily infected conjunctivitis |
Hyperpapillary conjunctivitis | |
catarrhal conjunctivitis | |
Perennial conjunctivitis | |
Nonpurulent conjunctivitis | |
Nonpurulent forms of conjunctivitis | |
Nonpurulent conjunctivitis | |
Non-infectious conjunctivitis | |
Subacute conjunctivitis | |
Trachoma conjunctivitis | |
H60.5 Acute otitis externa, noninfectious | Acute otitis externa |
H65.0 Acute serous otitis media | middle ear catarrh |
Otitis media acute | |
Otitis secretory | |
Otitis media | |
Otitis media acute serous | |
Otitis media secretory | |
tubootitis | |
H65.1 Other acute nonsuppurative otitis media | Acute otitis media |
H66.3 Other chronic suppurative otitis media | Purulent otitis media |
Otitis media chronic purulent | |
Chronic suppurative otitis media | |
Chronic suppurative otitis media | |
Chronic otitis media | |
J01.9 Acute sinusitis, unspecified | allergic sinusitis |
Pain in sinusitis | |
Inflammation of the sinuses | |
Sinusitis | |
Acute sinusitis | |
Purulent sinusitis | |
catarrhal sinusitis | |
Polypous sinusitis | |
Sinusitis | |
J03.9 Acute tonsillitis, unspecified (tonsillitis, agranulocytic) | Angina |
Angina alimentary-hemorrhagic | |
Angina secondary | |
Angina primary | |
Angina follicular | |
Angina | |
Bacterial tonsillitis | |
Inflammatory diseases of the tonsils | |
Throat infections | |
Catarrhal angina | |
Lacunar angina | |
Acute angina | |
Acute tonsillitis | |
Tonsillitis | |
acute tonsillitis | |
Tonsillar angina | |
Follicular angina | |
Follicular tonsillitis | |
J86 Pyothorax | Purulent pleurisy |
bacterial destruction of the lungs | |
Purulent pleurisy | |
empyema | |
Empyema of the lungs | |
Empyema of the lung | |
Pleural empyema | |
K05 Gingivitis and periodontal disease | Inflammatory gum disease |
Gingivitis | |
Hyperplastic gingivitis | |
Oral disease | |
Catarrhal gingivitis | |
Bleeding from gums | |
Epstein cysts | |
Erythematous gingivitis | |
Ulcerative gingivitis | |
K12 Stomatitis and related lesions | Bacterial stomatitis |
Inflammatory diseases of the oral cavity | |
Inflammatory diseases of oral tissues | |
Inflammatory processes in the oral cavity | |
Fungal diseases of the oral cavity | |
Fungal infections of the mouth | |
Fungal infectious and inflammatory diseases of the oral cavity | |
Oral disease | |
Infectious and inflammatory disease of the oral cavity | |
Exacerbation of inflammatory diseases of the pharynx and oral cavity | |
Recurrent ulcerative stomatitis | |
Stomatitis | |
Stomatitis | |
Angular stomatitis | |
Chronic recurrent stomatitis | |
Erosive and ulcerative lesions of the oral mucosa | |
Erosive and ulcerative lesions of the oral mucosa | |
Erosion of the oral mucosa | |
Ulcerative-necrotic diseases of the oral mucosa | |
Ulcerative-necrotic diseases of the oral mucosa | |
Ulcerative-necrotic lesions of the oral mucosa | |
Ulcerative necrotic gingivostomatitis | |
Ulcerative stomatitis | |
L02 Skin abscess, furuncle and carbuncle | Abscess |
Skin abscess | |
Carbuncle | |
Skin carbuncle | |
Furuncle | |
Skin furuncle | |
Furuncle of the external auditory canal | |
Furuncle of the auricle | |
Furunculosis | |
Furuncles | |
Chronic recurrent furunculosis | |
L89 Decubital ulcer | Secondarily infected bedsores |
Gangrene decubital | |
Decubital gangrene | |
bedsore | |
bedsores | |
L98.4 Chronic skin ulcer, not elsewhere classified | Secondarily infected trophic ulcers |
Long-term non-healing skin ulcer | |
skin ulceration | |
skin ulcer | |
Weeping ulcers | |
septic ulcer | |
chronic ulcers | |
Chronic skin ulcers | |
Chronic skin ulcer | |
Ulcers are sluggish | |
T14.1 Open wound, body region unspecified | Secondary healing processes |
Weakly granulating wounds | |
Slowly healing wounds | |
sluggish wounds | |
deep wounds | |
festering wound | |
Granulating wounds | |
Long-term non-healing wound | |
Long-term non-healing wound and ulcer | |
Long-term non-healing soft tissue wound | |
Wound healing | |
wound healing | |
Capillary bleeding from superficial wounds | |
bleeding wound | |
Radiation wounds | |
Slowly epithelializing wounds | |
Small cuts | |
festering wounds | |
Violation of wound healing processes | |
Violation of the integrity of the skin | |
Violations of the integrity of the skin | |
Violations of the integrity of the skin | |
Small cuts | |
Uninfected wounds | |
Uncomplicated wounds | |
Operating wound | |
Primary treatment of superficial contaminated wounds | |
Primary wound care | |
Primary delayed wound care | |
Badly scarring wound | |
Poor wound healing | |
Poor healing wound | |
superficial wound | |
Superficial wound with weak exudation | |
Wound | |
The wound is large | |
bite wound | |
Wound process | |
Wounds | |
sluggish wounds | |
Stump wounds | |
gunshot wounds | |
Wounds with deep cavities | |
Difficulty healing wounds | |
Difficulty healing wounds | |
chronic wounds | |
T30 Thermal and chemical burns, unspecified | Pain syndrome in burns |
Pain with burns | |
Burn pain | |
Slowly healing post-burn wounds | |
Deep burns with wet eschar | |
Deep burns with copious compartments | |
deep burn | |
laser burn | |
Burn | |
Burn of the rectum and perineum | |
Burn with weak exudation | |
burn disease | |
Burn injury | |
Superficial burn | |
Superficial burn I and II degree | |
Superficial skin burns | |
Post-burn trophic ulcer and wound | |
Post-burn complication | |
Fluid loss from burns | |
Sepsis burn | |
Thermal burns | |
Thermal skin lesions | |
Thermal burn | |
Trophic post-burn ulcers | |
chemical burn | |
Surgical burn | |
T79.3 Post-traumatic wound infection, not elsewhere classified | Inflammation after surgery and trauma |
Inflammation after injury | |
Secondary infection of skin lesions and mucous membranes | |
deep wounds | |
festering wound | |
Purulent-necrotic phase of the wound process | |
Purulent-septic diseases | |
festering wounds | |
Purulent wounds with deep cavities | |
Small granulating wounds | |
Disinfection of purulent wounds | |
Wound infections | |
Wound infections | |
Wound infection | |
Infected and non-healing wound | |
Infected postoperative wound | |
infected wound | |
Infected skin wounds | |
Infected burns | |
infected wounds | |
Festering postoperative wounds | |
Extensive purulent-necrotic process of soft tissues | |
Burn infection | |
Burn infection | |
Perioperative infection | |
Poorly healing infected wound | |
Postoperative and purulent-septic wound | |
Postoperative wound infection | |
wound infection | |
wound botulism | |
Wound infections | |
Purulent wounds | |
Wounds infected | |
Reinfection of granulating wounds | |
Sepsis post-traumatic | |
Z100* CLASS XXII Surgical practice | Abdominal surgery |
Adenomectomy | |
Amputation | |
Angioplasty of coronary arteries | |
Angioplasty of the carotid arteries | |
Antiseptic skin treatment for wounds | |
Antiseptic hand treatment | |
Appendectomy | |
Atherectomy | |
Balloon coronary angioplasty | |
Vaginal hysterectomy | |
Crown bypass | |
Interventions on the vagina and cervix | |
Bladder interventions | |
Intervention in the oral cavity | |
Restorative and reconstructive operations | |
Hand hygiene of medical personnel | |
Gynecological surgery | |
Gynecological interventions | |
Gynecological operations | |
Hypovolemic shock during surgery | |
Disinfection of purulent wounds | |
Disinfection of wound edges | |
Diagnostic interventions | |
Diagnostic procedures | |
Diathermocoagulation of the cervix | |
Long-term surgery | |
Replacement of fistula catheters | |
Infection during orthopedic surgery | |
Artificial heart valve | |
cystectomy | |
Brief outpatient surgery | |
Short-term operations | |
Short term surgical procedures | |
Cricothyrotomy | |
Blood loss during surgery | |
Bleeding during surgery and in the postoperative period | |
Culdocentesis | |
Laser coagulation | |
Laser coagulation | |
Laser coagulation of the retina | |
Laparoscopy | |
Laparoscopy in gynecology | |
CSF fistula | |
Minor gynecological surgeries | |
Minor surgical interventions | |
Mastectomy and subsequent plasty | |
Mediastinotomy | |
Microsurgical operations on the ear | |
Mucogingival operations | |
Suturing | |
Minor surgical interventions | |
Neurosurgical operation | |
Immobilization of the eyeball in ophthalmic surgery | |
Orchiectomy | |
Complications after tooth extraction | |
Pancreatectomy | |
Pericardectomy | |
The period of rehabilitation after surgical operations | |
The period of convalescence after surgical interventions | |
Percutaneous transluminal coronary angioplasty | |
Pleural thoracocentesis | |
Pneumonia postoperative and post-traumatic | |
Preparation for surgical procedures | |
Preparing for surgery | |
Preparation of the surgeon's hands before surgery | |
Preparing the colon for surgery | |
Postoperative aspiration pneumonia in neurosurgical and thoracic operations | |
Postoperative nausea | |
Postoperative bleeding | |
Postoperative granuloma | |
postoperative shock | |
Early postoperative period | |
Myocardial revascularization | |
Resection of the apex of the tooth root | |
Resection of the stomach | |
Bowel resection | |
Resection of the uterus | |
Liver resection | |
Resection of the small intestine | |
Resection of part of the stomach | |
Reocclusion of the operated vessel | |
Bonding tissue during surgery | |
Removal of stitches | |
Condition after eye surgery | |
Condition after surgery | |
Condition after surgical interventions in the nasal cavity | |
Condition after resection of the stomach | |
Condition after resection of the small intestine | |
Condition after tonsillectomy | |
Condition after removal of the duodenum | |
Condition after phlebectomy | |
Vascular surgery | |
Splenectomy | |
Sterilization of the surgical instrument | |
Sterilization of surgical instruments | |
Sternotomy | |
Dental operations | |
Dental intervention on periodontal tissues | |
Strumectomy | |
Tonsillectomy | |
Thoracic surgery | |
Thoracic surgery | |
Total gastrectomy | |
Transdermal intravascular coronary angioplasty | |
Transurethral resection | |
Turbinectomy | |
Removal of a tooth | |
Cataract removal | |
Removal of cysts | |
Tonsil removal | |
Removal of fibroids | |
Removal of mobile milk teeth | |
Removal of polyps | |
Removal of a broken tooth | |
Removal of the body of the uterus | |
Suture removal | |
Urethrotomy | |
CSF fistula | |
Frontoethmoidogaimorotomy | |
Surgical infection | |
Surgical treatment of chronic leg ulcers | |
Surgery | |
Surgery in the anus | |
Surgical operation on the large intestine | |
Surgical practice | |
surgical procedure | |
Surgical interventions | |
Surgical interventions on the gastrointestinal tract | |
Surgical interventions on the urinary tract | |
Surgical interventions on the urinary system | |
Surgical interventions on the genitourinary system | |
Surgical interventions on the heart | |
Surgical manipulations | |
Surgical operations | |
Surgical operations on the veins | |
Surgical intervention | |
Surgical intervention on the vessels | |
Surgical treatment of thrombosis | |
Surgery | |
Cholecystectomy | |
Partial resection of the stomach | |
Transperitoneal hysterectomy | |
Percutaneous transluminal coronary angioplasty | |
Percutaneous transluminal angioplasty | |
Bypass coronary arteries | |
Tooth extirpation | |
Extraction of milk teeth | |
Pulp extirpation | |
extracorporeal circulation | |
Tooth extraction | |
Extraction of teeth | |
Cataract extraction | |
Electrocoagulation | |
Endourological interventions | |
Episiotomy | |
Ethmoidectomy |
Furacilin
International non-proprietary name
Nitrofural
Dosage form
Tablets 0.02 g
Compound
One tablet contains
active substance- nitrofural (furatsilin) 0.02 g
excipient- sodium chloride 0.8 g
Description
Tablets of yellow or greenish-yellow color with an uneven surface color, flat-cylindrical with a risk and a chamfer.
Pharmacotherapeutic group
Antiseptics and disinfectants. Nitrofuran derivatives. Nitrofural.
ATX code D08AF01
Pharmacological properties
Pharmacokinetics
Easily passes through histohematic barriers and is evenly distributed in fluids and tissues. The main way of transformation in the body is the reduction of the nitro group. It is excreted by the kidneys and partly with bile in
intestinal lumen. The maximum concentration in the urine is reached 6 hours after ingestion.
Pharmacodynamics
Furacilin is an antimicrobial agent. Active against gram-positive and gram-negative bacteria (Staphylococcus spp., Streptococcus spp., Shigella dysenteria spp., Shigella flexneri spp., Shigella boydii spp., Shigella sonnei spp., Escherichia coli, Clostridium perfrigens, Salmonella spp., etc.) Effective with the resistance of microorganisms to other antimicrobial agents (not from the group of nitrofuran derivatives). Suppresses the activity of fungal flora. It has a mechanism of action different from other chemotherapeutic agents: microbial flavoproteins restore the 5-nitro group, the resulting highly reactive amine derivatives change the conformation of proteins, including ribosomal ones, and other macromolecules, causing cell death. Resistance develops slowly and does not reach a high degree. Increases the absorption capacity of the reticuloendothelial system, enhances phagocytosis.
Indications for use
minor skin lesions (including abrasions, scratches, cracks, cuts), purulent wounds, bedsores, ulcers
burns II and III degree
furunculosis of the external auditory canal, acute external and otitis media
purulent-inflammatory processes of the paranasal sinuses
angina, stomatitis, gingivitis
Dosage and administration
Outwardly, furatsilin is used in the form of an aqueous 0.02% (1:5000) solution and an alcohol 0.066% (1:1500) solution.
- with purulent wounds, bedsores and ulcers, burns II and III degree, to prepare the granulating surface for skin grafting and for the secondary suture, irrigate the wound with an aqueous solution of furacilin and apply wet dressings
- with chronic purulent otitis, furuncles of the external auditory canal and empyema of the paranasal sinuses apply in the form of drops an alcohol solution of furacilin
- for washing the maxillary (maxillary) and other paranasal sinuses use an aqueous solution of furacilin
- with angina and stomatitis rinsing with an aqueous solution of the drug is prescribed.
To prepare an aqueous solution, 1 tablet of furacilin is dissolved in 100 ml of distilled water. An alcohol solution is prepared in 70% ethanol (1 tablet of furacilin is dissolved in 100 ml of 70% ethyl alcohol). -6 drops into the external auditory canal. For rinsing the mouth and throat - 20 mg (1 tablet) is dissolved in 100 ml of boiled water.
The course of treatment should not exceed 3-5 days. If symptoms persist, it is recommended to consult a doctor.
Side effects
- allergic reactions: pruritus, dermatitis
nausea, vomiting, diarrhea
Contraindications
Increased individual sensitivity to the drug
Allergodermatoses
Drug Interactions
Not installed
special instructions
Pregnancy and lactation
Can be used during pregnancy and lactation.
Features of the influence of the drug on the ability to drive a vehicle or potentially dangerous mechanisms
There are no data on adverse effects on the ability to drive a vehicle or potentially dangerous mechanisms.
Overdose
Not identified
Release form and packaging
10 tablets are placed in a blister-free package made of polyethylene-coated paper.
600 contour non-cell packs with an equal number of instructions for medical use in the state and Russian languages are placed in a cardboard box.
Storage conditions
In a dry, dark place, at a temperature of 15 to 25 ºC.
Keep out of the reach of children!
Shelf life
Do not use after the expiration date.
Terms of dispensing from pharmacies
Without recipe
Manufacturer
Registration certificate holder
OAO Irbit Chemical-Pharmaceutical Plant, Russia
623856, Sverdlovsk region, Irbit, Kirova st., 172.
organization address,accepting claims from consumers on the quality of products (goods)
OAO Irbit Chemical-Pharmaceutical Plant, Russia